Article: article from journal or magazin.
Traitements des facteurs de risque cardiovasculaire et dépistage de la maladie coronarienne dans le diabète de type 2 [Treatments for cardiovascular risk factors and screening for coronary artery disease in type 2 diabetes mellitus]
Revue Médicale Suisse
The recent ACCORD and DIAD studies revealed results which could modify treatments and the screening of diabetes vascular complications. Indeed, ACCORD shows no benefit on the prevention of diabetes vascular complications by aggressive treatment of hypertension or the combined treatment of the dyslipidemia. The intensive treatment of the blood glucose, if associated with severe hypoglycemias, increases mortality. DIAD revealed 20% of silent myocardial ischaemia in diabetic patients but no beneficial effect on the cardiovascular mortality. A careful reading of these studies in the light of long term studies such as UKPDS and STENO reveals that these negative results are generated by a too short follow-up and too aggressive objectives. The long term studies reveal that more realistic objectives remain beneficial.
Antilipemic Agents/therapeutic use, Coronary Disease/diagnosis, Coronary Disease/epidemiology, Diabetes Mellitus, Type 2/complications, Dyslipidemias/complications, Dyslipidemias/drug therapy, Evidence-Based Medicine, Humans, Hypertension/complications, Hypertension/drug therapy, Mass Screening, Procetofen/therapeutic use, Randomized Controlled Trials as Topic, Risk Factors
Last modification date